Mira Pharmaceuticals (MIRA) Research & Development (2022 - 2025)

Mira Pharmaceuticals has disclosed Research & Development across 4 years of filings, most recently posting $496543.0 for Q4 2025.

• Research & Development for Q4 2025 came in at $496543.0, down 42.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 million (down 47.97% YoY), and the FY2025 annual result was $1.7 million, down 47.97% from the prior year.
• Research & Development came in at $496543.0 for Q4 2025 at Mira Pharmaceuticals, up from $412639.0 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $1.1 million in Q3 2024 to a low of $271606.0 in Q1 2023.
• The 4-year median for Research & Development is $614462.0 (2024), against an average of $638389.5.
• Across the five-year window, Research & Development soared 180.66% in 2024 and sank 61.34% in 2025, its largest moves.
• Mira Pharmaceuticals' Research & Development stood at $884757.0 in 2022, then plunged by 56.25% to $387123.0 in 2023, then soared by 122.52% to $861441.0 in 2024, then slumped by 42.36% to $496543.0 in 2025.
• The last three Research & Development figures came in at $496543.0 (Q4 2025), $412639.0 (Q3 2025), and $496197.0 (Q2 2025), per Business Quant data.